News - Global, Patents

Filter

Current filters:

GlobalPatents

Popular Filters

Structuring your investment to protect IP rights – the case of compulsory licensing

21-03-2014

Pharmaceutical companies may obtain additional international law protection against unlawful compulsory…

GlobalPatentsPharmaceuticalPolitics

Patent expiries will push Parkinson’s drug market lower by 2019

17-12-2013

Due to upcoming patent expirations for four high-profile drugs, the global Parkinson’s disease (PD)…

GlobalImpax LaboratoriesMarkets & MarketingNeurologicalNewron PharmaPatentsPharmaceuticalpimavanserinRytarysafinamide

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

WTO TRIPS resolution excludes pharma from IP extension exemption for least-developed countries

12-06-2013

The Council for TRIPS (Trade-Related Aspects of Intellectual Property Rights) yesterday (June 11) adopted…

GlobalPatentsPharmaceutical

USTR releases "Special 301" report that disappoints PhRMA

03-05-2013

The Office of the United States Trade Representative (USTR) has released its annual "Special 301" Report…

GlobalNorth AmericaPatentsPharmaceuticalPolitics

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Medicines Patent Pool and ViiV Healthcare collaborate to treat pediatric HIV

28-02-2013

The Medicines Patent Pool (MPP) this week announced the launch of a new collaboration with ViiV Healthcare…

AbacavirAnti-viralsGenericsGlobalPatentsPharmaceuticalViiV Healthcare

MEPS urge EU action to combat "biopiracy"

15-01-2013

MEPS urge EU action to combat "biopiracy"

EuropeGlobalPatentsPharmaceutical

Generic drugs market will reach $127.8 billion in 2013, Visiongain predicts

20-11-2012

The value of the world prescription generic drug industry stands at $110.8 billion in 2011 and is forecast…

GenericsGlobalMarkets & MarketingPatents

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Middle-income countries flex muscles to overcome patents in face of unaffordable drug prices

29-07-2012

Middle-income countries are increasingly taking measures to overcome the patents that price drugs out…

Anti-viralsGenericsGlobalPatentsPharmaceuticalPricing

Global medicines spending set to rebound, reaching nearly $1.2 trillion by 2016, says IMS

13-07-2012

Following several years of slowing growth, the global market for medicines is poised to rebound from…

BiotechnologyGenericsGlobalHealthcareMarkets & MarketingPatentsPharmaceutical

Intellectual property encourages collaboration, R&D in developing economies

21-06-2012

The USA-based Biotechnology Industry Organization (BIO) unveiled a report on the role of intellectual…

BiotechnologyGlobalPatentsPharmaceuticalResearch

EU draft opinion on ACTA still flawed, says MSF, urging member states not to sign

11-05-2012

The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting…

EuropeGenericsGlobalPatentsPharmaceuticalPolitics

USTR issues Special 301 report relating to IPR

03-05-2012

The United States Trade Representative (USTR) this week issued the Special 301 Report, an annual review…

GlobalMarkets & MarketingPatentsPharmaceutical

Consumer groups call for condemnation of ACTA independent of ECJ

27-03-2012

Health-related consumer groups Health Action International (HAI) Europe, Oxfam, Medecins Sans Frontieres…

EuropeGenericsGlobalLegalPatentsPharmaceuticalPoliticsRegulation

Likelihood of big uptake of biosimilars by 2020 questioned

15-03-2012

The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this…

BiotechnologyGenericsGlobalMarkets & MarketingPatentsRegulation

What lies ahead: pharma and health care trends for 2012?

09-01-2012

In what probably comes as no surprise, many of the challenges now faced by the pharmaceutical industry…

GenericsGlobalHealthcareMarkets & MarketingPatentsPharmaceuticalPricing

Economics of Generics, according to Zacks

11-12-2011

Besides the multitude of the world’s poor, the aging population (2 billion people of 60 years or…

GenericsGlobalHealthcareMarkets & MarketingPatents

PhRMA welcomes Russia’s progress toward WTO accession, but has reservations on IP

14-11-2011

The Working Party on Russia’s Accession to the World Trade Organization (WTO) in Geneva said last…

GlobalPatentsPharmaceuticalPolitics

Superior combo therapies to sustain HIV/AIDS market growth despite major patent expiries

19-10-2011

The HIV/AIDS therapeutics market is a growing therapy sector, with the USA dominating in terms of revenues.…

Anti-viralsGlobalMarkets & MarketingPatentsPharmaceutical

USTR Embraces “TEAM” approach in TPP talks; Senators back 12-year exclusivity for biologics

15-09-2011

September 12 marked the beginning of the eighth round of Trans-Pacific Partnership (TPP) negotiations,…

BiotechnologyGenericsGlobalNorth AmericaPatentsPharmaceuticalPolitics

Global generic drug revenues to reach $137.6 billion in 2015, says Visiongain

14-09-2011

Worldwide generic drug revenues will reach a value of $137.6 billion in 2015, according to a new report…

GenericsGlobalMarkets & MarketingPatents

Back to top